45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Ralph P. Ermoian; John Breneman; David O. Walterhouse; Yueh‐Yun Chi; Jane Meza; James Anderson; Douglas S. Hawkins; Andrea A. Hayes‐Jordan; David M. Parham; Torunn I. Yock; Sarah S. Donaldson; Suzanne L. Wolden
Author Information: Department of Radiation Oncology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.